Series A Healthtech Investors in the US
We've mapped 14 of the most active series a Healthtech investors funding founders in the US, with cheques $25K–$18M.
We've mapped 14 of the most active series a Healthtech investors funding founders in the US — 13 VCs and 1 Private Equity. Cheque sizes across this segment run $25K–$18M.
When raising series a for a Healthtech company in the US, founders should lead with the investors whose stage and cheque size actually match the round — not just the best-known names. 14 of these profiles have been verified in the last review pass. Sign in to see each investor's full thesis, cheque range, and how closely they fit your specific company.
Tamarisc Ventures
Early-stage VC investing in PropTech, edtech, medtech and climate tech companies improving the built environment; team distributed Boston/Los Angeles. Sign in to see full profile →
Rockwood Equity
Cleveland-based lower middle-market private equity firm targeting buyout and recapitalization investments across the US. Sign in to see full profile →
Red Cedar Ventures
Venture subsidiary of the MSU Research Foundation supporting early-stage high-tech startups emerging from Michigan State University. Sign in to see full profile →
Oriza Ventures
Early-stage VC headquartered in Santa Clara investing in US tech startups with cross-border China expansion expertise. Sign in to see full profile →
MIR Ventures
Palo Alto-based pre-seed/seed VC (founded 2017) backing companies at the intersection of communication, collaboration and convening - the 'three Cs' that dee… Sign in to see full profile →
JK&B Capital
JK&B Capital is a Chicago-based venture capital firm founded in 1996 by David Kronfeld, with more than USD 1.1bn in cumulative assets under management. Sign in to see full profile →
HALLEY Venture Partners
California VC focused on building scalable companies in the legal cannabis and hemp sectors. Sign in to see full profile →
Emerald Development Manager
New York-based early-stage VC backing elite scientific/engineering teams in cybersecurity/SaaS, biotech/healthcare IT, and clean tech/industrial tech. Sign in to see full profile →
Drads Capital
Boston VC investing in life sciences, biotech and AI; portfolio includes Amylyx, Hyperfine and ROKIT Healthcare. Sign in to see full profile →
DHVC
Palo Alto VC (formerly Danhua Capital) investing in AI, AR/VR, robotics, fintech, healthcare, and enterprise tech. Sign in to see full profile →
Bertelsmann Digital
Bertelsmann's NYC-based corporate VC investing in seed/early-stage SaaS, fintech, web3, and next-gen media. Sign in to see full profile →
Applied Ventures
Applied Ventures is the corporate venture capital arm of Applied Materials (NASDAQ: AMAT), founded 2006 and based in Santa Clara, CA. Sign in to see full profile →
Amgen Ventures
Corporate venture arm of Amgen (since 2004); early-stage biotech investments in oncology, inflammation, neuroscience, cardiovascular. Sign in to see full profile →
11.2 Capital
Early-stage VC investing in breakthrough deep tech: AI, cybersecurity, quantum, robotics, new space, bioengineering, climate. Sign in to see full profile →
Looking for the right investors for your specific company? MatchFund ranks every investor against your profile, sector, stage, and traction — not just the obvious ones.
Get matched →Directory last updated: May 2026